These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3235889)

  • 21. The significance of moderate and severe inflammation on class I Papanicolaou smear.
    Lawley TB; Lee RB; Kapela R
    Obstet Gynecol; 1990 Dec; 76(6):997-9. PubMed ID: 2234731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Occurrence of recurrence after regression of low-grade dysplasia in vaginal cytological smears].
    Engh V; Eide TJ
    Tidsskr Nor Laegeforen; 1991 Jan; 111(3):328-9. PubMed ID: 2000616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear DNA content analysis by static cytometry in cervical intraepithelial lesions using retrospective series of previously stained PAP smears.
    Shirata NK; Gomes NS; Garcia EA; Longatto Filho A
    Adv Clin Path; 2001 Jul; 5(3):87-91. PubMed ID: 11753880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS).
    Emerson RE; Puzanov A; Brunnemer C; Younger C; Cramer H
    Diagn Cytopathol; 2002 Sep; 27(3):153-7. PubMed ID: 12203862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of uterine cervical cytology and biopsy results: indications and outcomes for colposcopy.
    Swinker M; Cutlip AC; Ogle D
    J Fam Pract; 1994 Jan; 38(1):40-4. PubMed ID: 8289050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-positive squamous cell carcinoma in cervical smears: cytologic-histologic correlation in 19 cases.
    Levine PH; Elgert PA; Mittal K
    Diagn Cytopathol; 2003 Jan; 28(1):23-7. PubMed ID: 12508178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the HPV L1 capsid protein in prognosis of mild and moderate dysplasia of the cervix uteri.
    Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Manestar M
    Coll Antropol; 2010 Jun; 34(2):419-23. PubMed ID: 20698112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [DNA content and prognosis in atypical cervix epithelium].
    Bergleiter R
    Zentralbl Gynakol; 1986; 108(19):1164-9. PubMed ID: 3811665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Koilocytotic atypia and underlying dysplasia.
    Shepherd J; Lynch W
    J Fam Pract; 1991 Aug; 33(2):168-71. PubMed ID: 1890397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus screening for women with atypical Papanicolaou smears.
    Borst M; Butterworth CE; Baker V; Kuykendall K; Gore H; Soong SJ; Hatch KD
    J Reprod Med; 1991 Feb; 36(2):95-9. PubMed ID: 1849177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure.
    Farley J; Uyehara C; Hashiro G; Belnap C; Birrer M; Salminen E
    Gynecol Oncol; 2004 Feb; 92(2):596-602. PubMed ID: 14766253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations on the development of dysplasia.
    Heinzl S; Szalmay G; Jochum L; Roemer V
    Acta Cytol; 1982; 26(4):453-6. PubMed ID: 6957097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance.
    Raab SS; Bishop NS; Zaleski MS
    Gynecol Oncol; 1999 Sep; 74(3):460-4. PubMed ID: 10479510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expectation values for low-resolution slit-scan flow prescreening: influence of nuclear shape and DNA density.
    Mullaney PF; Mann R; Seger GH; Achatz M
    Anal Quant Cytol; 1982 Jun; 4(2):115-22. PubMed ID: 6180664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of the minimally abnormal Papanicolaou smear.
    Montz FJ; Monk BJ; Fowler JM; Nguyen L
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):385-8. PubMed ID: 1495693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biometric research in the diagnosis of precancerous states and endocervical cancer].
    Novik VI; Agroskin LS; Papaian GV; Solov'eva LV
    Arkh Patol; 1989; 51(12):45-50. PubMed ID: 2629663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytofluorimetric research on the epithelium of the cervix uteri in malignancy].
    Ganina KP; Nosa PP; Boroda AN; Klevetenko MP
    Tsitol Genet; 1993; 27(2):30-7. PubMed ID: 8212323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.